We could not find any results for:
Make sure your spelling is correct or try broadening your search.
WOODCLIFF LAKE, N.J., Feb. 2 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc. (NYSE:PRX) announced today that it will host a conference call and live webcast on Wednesday, February...
Option to collaborate on three new products Relationship built on successful development of ondansetron oral soluble film currently under FDA review WARREN, N.J., Jan. 5 /PRNewswire/ -- MonoSol...
Par to Begin Shipping Tramadol ER Immediately WOODCLIFF LAKE, N.J., Nov. 16 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc. (NYSE:PRX) today announced that it has received final...
Achieves Record Quarterly Gross Margin of $92 Million WOODCLIFF LAKE, N.J., Nov. 6 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc. (NYSE:PRX) today reported results for the third...
AstraZeneca PLC (AZN) has asked a U.S. court for an early ruling on a patent dispute over the U.K. company's blockbuster statin Crestor which is being challenged by a number of generic firms...
Par to Begin Shipping Nateglinide Immediately WOODCLIFF LAKE, N.J., Sept. 10 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc. (NYSE:PRX) today announced that it has received final...
Brand & Generic Business Units Drive Strong Earnings WOODCLIFF LAKE, N.J., Aug. 4 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc. (NYSE:PRX) today reported results for the second...
Watson Pharmaceuticals Inc. (WPI) reported a 12% drop in second-quarter earnings, due to items, but raised its 2009 financial expectations citing the expected approval of a generic version of...
WOODCLIFF LAKE, N.J., July 15 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc. (NYSE:PRX) announced today that it will host a conference call and live webcast on Tuesday, August 4...
The U.S. Department of Justice on Monday took a skeptical view on the legality of pharmaceutical patent settlements that delay the introduction of generic drugs, the latest change in antitrust...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.0005 | -20 | 0.0025 | 0.0025 | 0.002 | 2616988 | 0.0020105 | DE |
4 | -0.001 | -33.3333333333 | 0.003 | 0.003 | 0.0015 | 20268318 | 0.00206638 | DE |
12 | 0 | 0 | 0.002 | 0.005 | 0.001 | 10876973 | 0.00237986 | DE |
26 | -0.001 | -33.3333333333 | 0.003 | 0.005 | 0.001 | 6479450 | 0.00241073 | DE |
52 | -0.006 | -75 | 0.008 | 0.009 | 0.001 | 4505950 | 0.00289213 | DE |
156 | -0.032 | -94.1176470588 | 0.034 | 0.038 | 0.001 | 1860052 | 0.00542297 | DE |
260 | -0.078 | -97.5 | 0.08 | 0.089 | 0.001 | 1495452 | 0.01992844 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions